^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    BIOMARKER:

    MLL rearrangement + PICALM-MLLT10 fusion + SET-NUP214 fusion

    i
    Other names: HTRX1, HTRX, MLL1A, Mixed Lineage Leukemia 1, Myeloid/Lymphoid Or Mixed-Lineage Leukemia Protein 1, CXXC7, MLL1, TRX1, Zinc Finger Protein HRX, Trithorax-Like Protein, ALL-1, Lysine (K)-Specific Methyltransferase 2A, CXXC-Type Zinc Finger Protein 7, Histone-Lysine N-Methyltransferase 2A, Myeloid/Lymphoid Or Mixed-Lineage Leukemia, Lysine Methyltransferase 2A, MLL, Myeloid/Lymphoid Or Mixed-Lineage Leukemia, KMT2A, PICALM, Phosphatidylinositol Binding Clathrin Assembly Protein, CALM, Phosphatidylinositol-Binding Clathrin Assembly Protein, Clathrin Assembly Lymphoid Myeloid Leukemia Protein, CLTH, PICALM, LAP, MLLT10, MLLT10 Histone Lysine Methyltransferase DOT1L Cofactor, AF10, Myeloid/Lymphoid Or Mixed-Lineage Leukemia; Translocated To, 10, ALL1-Fused Gene From Chromosome 10 Protein, Protein AF-10, Myeloid/Lymphoid Or Mixed-Lineage Leukemia (Trithorax (Drosophila) Homolog); Translocated To, 10, Myeloid/Lymphoid Or Mixed-Lineage Leukemia (Trithorax Homolog, Drosophila); Translocated To, 10, Type III AF10 Protein, Type IV AF10 Protein, Type I AF10 Protein, SET, SET Nuclear Proto-Oncogene, Inhibitor Of Granzyme A-Activated DNase, HLA-DR-Associated Protein II, PHAPII, TAF-I, SET Translocation (Myeloid Leukemia-Associated), Protein Phosphatase Type 2A Inhibitor, Phosphatase 2A Inhibitor I2PP2A, Chromatin Remodelling Factor, Protein SET, TAF-IBETA, IPP2A2, Template-Activating Factor-I, Chromatin Remodelling Factor, Inhibitor-2 Of Protein Phosphatase-2A, Template-Activating Factor-I, Template-Activating Factor I, SET Nuclear Oncogene, I2PP2A, MRD58, NUP214, Nucleoporin 214, Nuclear Pore Complex Protein Nup214, CAN Protein, Putative Oncogene, Nucleoporin 214kDa, CAIN, Nucleoporin 214kD (CAIN), 214 KDa Nucleoporin, Nucleoporin Nup214, Protein CAN, IIAE9
    Entrez ID:
    8021; 6418; 8028; 8301
    Related biomarkers:
    Mutation
    Fusion
    Others
    Associations
    News
    Trials